Bayser
Publications,
Conferences and Tutorials
Publications:
"Peers
of Influence", by Jean-Patrick Tsang PhD MBA (INSEAD),
Medical Marketing and Media, Feb 2004
first page:
.jpg .pdf (right-click
to download)
"Distilling
Influence Networks and Referral Patterns from Patient-Level Data",
by Jean-Patrick Tsang PhD MBA (INSEAD) and Igor Rudychev PhD, Product
Management Today, April 2003.
first page:
.jpg .pdf (right-click
to download)
"Hospital
to Home - Leveraging Hospital-Retail Spillover", by
Jean-Patrick Tsang PhD MBA (INSEAD), Pharmaceutical Executive, July
2003
first page: .jpg .pdf (right-click
to download)
"Patient Data
Come of Age", by Jean-Patrick Tsang PhD MBA (INSEAD),
Pharmaceutical Executive, May 2003 and The International Pharmaceutical
Review 2003, pp. 132-135
first page:
.jpg .pdf (right-click
to download)
"Patient-Level
Data: A New Level of Analysis", by Jean-Patrick Tsang
PhD MBA (INSEAD), Pharma Marketing News, Vol. 2, No. 7, July 2003
first page:
.jpg (right-click
to download)
Sales
Territory Alignment Key to Marketing Success, by
Jean-Patrick Tsang PhD MBA (INSEAD), Drug Marketing, Vol.
4 No. 10, Mar 13, 2002.
Micromarketing
An Individual Approach, by Jean-Patrick Tsang PhD MBA (INSEAD), Pharmaceutical Executive, Dec 2001.
first page:
.jpg (right-click
to download)
Endowing
Reasoning Capability to Matching/Scrubbing Algorithm, by
Jean-Patrick Tsang PhD MBA (INSEAD) and Igor Rudychev PhD, Journal of
Data Warehousing, October 2002.
Sales Force Strategy,
by Jean-Patrick Tsang PhD MBA (INSEAD), Pharmaceutical Representative, Feb 2002.
Conferences:
Building
sociograms of physicians using upstream targeting, IIR
Conference, Sheraton Rittenhouse Square Hotel, Philadelphia, PA Feb
24-26, 2004 (co-presentation with Sepracor).
Challenges
and opportunities involved in deploying patient-level data in
pharmaceutical companies, CBI 2nd annual conference,
Philadelphia, PA June 3-3, 2004.
Patient-Level
Data - Leverage emerging data to mazimize market potential,
Organizer and chairman of conference with CBI, Philadelphia, PA, June
5-6 2003.
Anonymous
Patient-Level Data - Leverage emerging data to mazimize market
potential, Organizer and Chairman of conference with CBI,
Philadelphia, PA, Nov 16-17 2003.
CRM
Analytics, Round Table Champion, "E-Pharma Summit",
Baltimore, MD, May 13-15 2003.
Form Strategic
Alliances to Support the Lifecycle Plan, CBIs Pharmaceutical
Product Lifecycle Strategies, Capital Hilton, Washington DC, November
15-16, 2001.
How
to harness the power of Patient-Level Data, workshop leader,
Med Ad News Conference on Pharmaceutical Marketing Partnerships, New
York, NY, April 19-21, 2004.
Identifying KOL's for MSL's", PEA
conference on "Best Practices for Medical Science Liaisons", Allertown
Crown Plaza, Chicago, June 25, 2004.
Optimizing
the use of Patient-Level Data to enhance your marketing capabilities,
chairman and leader of pre-conference workshop "Introduction to
classical and advanced patient-level analyses", PEA Conference, Park
Hyatt, Philadelphia, PA, March 22-23, 2004.
Nail
down true ROI, PMC 2003 Washington DC, Oct 2003
(co-presentation with Sanofi).
Forecasting
by combining multiple viewpoints, PMRG Seminar on Forecasting,
Fairfield NJ, Nov 11-13, 2002.
Identification
of Influencers using Patient-Level Data, PMRG Fall 2003, San
Diego, Sep 21-23, 2003.
Building GIGO-Free Response Models,
2002 PMSA Conference, New Orleans, April 28 May 1, 2002.
Measuring
Hospital-Retail Spillover: Bridging and Holistic Techniques,
2003 PMSA, Orlanda, FL, May 4-7, 2003.
Increasing your deal making IQ by looking at
what others did, SRIs 6th Intl Pharma & Biotech Licensing
Deal-Making Summit, Coronado Courtyard, San Diego, Jan 28-30, 2002.
Promotion-Response Models to Optimize your
Portfolio, SRIs 3rd Rx & Biotech Portfolio Management Conference,
Hyatt Hotel in Penn Landing, Philadelphia, Mar 25-27, 2002.
Lectures &
Training Workshops
ROI
Segmentation and Targeting
Decision Making under Uncertainty
Sales Force Effectiveness and
Managed Care Contracts
Patient-Level Data - Overview
and Analyses
Simulated Annealing and Genetic
Algorithm: The SAGA
Quotes:
- Daily Deal, Dec 19 2001, Novocell gets $5M for diabetes research
Jean-Patrick Tsang, a consultant with
Bayser Consulting in Skokie, Ill., an advisor to medical and biotech
startups, was a bit less sanguine about Novocell's future. "What they
are trying to do with a new cure for diabetes is a mammoth undertaking
and so, while their new partner appears to have the expertise, they need
to grow, and they probably need a lot more money to pull it off."
- Daily Deal, June 12 2002, Enanta tackles drug-resistant
bacteria
Chicago consulting firm Bayser
Consulting estimates that the macrolide antibiotics market alone is
worth $2.7 billion, considering Pfizer Inc.'s Zithromax antibiotic and
Abbott Laboratories' Biaxin.
If you would like to download a presentation,
give us a call at (847) 920-1000 or email us at
bayser@bayser.com.
